As interest in peptide research continues to expand, laboratories often seek standardized materials that support organized workflows and repeatable experimental procedures
"Efficacy and safety of co-administered once-weekly cagrilintide 24 mg with once-weekly semaglutide 24 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial"
With more late-stage clinical trial results forthcoming for this class of drugs, we will soon learn whether the promise of incretin-based therapies is justified
The anticancer effect would be achieved by subsequent systemic administration of the non-toxic prodrug, which would be converted to a toxic drug preferentially in the tumour cells
And it didnt stop until Tuesday
Because as of 2025 we do not have a method to alter your DNA that is genetically determined, much like how we cant alter height or IQ